@article{ab0ec1481aca4067be8caade92383fd2,
title = "Incidence of tumor lysis syndrome in patients with acute myeloid leukemia undergoing low-intensity induction with venetoclax",
author = "Stacy Diao and Nichols, {E. Dan} and Courtney DiNardo and Marina Konopleva and Jing Ning and Wei Qiao and Abhishek Maiti and DiPippo, {Adam J.}",
note = "Funding Information: Chun Feng, M.A., ASQ Six Sigma Black Belt, Sr. Informatics Analyst - Department of Pharmacy Medication Management & Analytics, Division of Pharmacy, University of Texas M.D. Anderson Cancer Center. Funding Information: S.D., E.N., J.N., W.Q., and A.D. have no disclosures. C.D. served as a consultant for AbbVie, Agios, Celgene, Daiichi Sankyo, Jazz, and Notable Labs. M.K. served as a consultant for AbbVie, Genentech, F. Hoffman La‐Roche, Stemline Therapeutics, Amgen, Forty‐Seven, and Kisoji. M.K. received research funding and clinical trial support from AbbVie, Genentech, F. Hoffman La‐Roche, Eli Lilly, Cellectis, Calithera, Ablynx, Stemline Therapeutics, Agios, Ascentage, and AstraZeneca. M.K. received royalties from Reata Pharmaceutical. A.M. received research funding from Celgene. The current affiliation for S.D., E.N., C.D., M.K., J.N., W.Q., A.M., and A.D. is The University of Texas MD Anderson Cancer Center. ",
year = "2021",
month = mar,
day = "1",
doi = "10.1002/ajh.26060",
language = "English (US)",
volume = "96",
pages = "E65--E68",
journal = "American journal of hematology",
issn = "0361-8609",
publisher = "John Wiley and Sons Inc.",
number = "3",
}